Velafax XL 150 mg tvrde kapsule s produljenim oslobađanjem
| Name | Velafax XL 150 mg tvrde kapsule s produljenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-045409982 |
| Active Substance | venlafaksinklorid |
| Composition | jedna kapsula s produljenim oslobađanjem sadrži 150 mg venlafaksina u obliku venlafaksinklorida |
| Pharmaceutical Form | Kapsula s produljenim oslobađanjem, tvrda |
| Manufacturer | Teva Pharma S.L.U., Zaragoza, Španjolska Teva Operations Poland Sp. z o.o., Krakow, Poljska |
| Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
| Marketing Authorisation Date | 18.05.2022 |
| MA Period of Validity | 18.05.2027 |
| Classification Number | UP/I-530-09/21-01/268 |
| Registration Number | 381-12-01/154-22-02 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | N06AX16 |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
